ALK Laboratorierne AS

Positive top-line results from a Phase III study of Stallergenes Greer PLC 's sublingual immunotherapy tablet for house dust mite (HDM) allergic rhinitis, STAGR320, completes the business turnaround

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

After recently raising a Series B funding of $32m from Chinese investors, EOC Pharma is planning to expand its team in clinical development, regulatory affairs and CMC (chemistry, manufacturing, and c

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer